Gregory Samios is the President and CEO of the Clinical Effectiveness business at Wolters Kluwer where he is leading efforts to reduce unwanted variability in care and measurably improve clinical effectiveness with industry-leading solutions.
Samios served as President and CEO of the Health Learning, Research, and Practice business from 2019 to 2021, and previously served as the President and CEO of Wolters Kluwer Legal & Regulatory U.S. business. He earned a Master of Business Administration from Duke University Fuqua School of Business and a BS/MS degree in Engineering from the University of Rochester.
Ultimately, to get generative AI in healthcare right we need input from the clinicians who will use these tools – and who understand the ramifications of applying AI without first rigorously testing applications to ensure they are safe and provide clear clinical value.
The creation of consistent and high value engagements with individuals across their digital and in-person engagements will enable these providers to both attract and retain consumers in the rapidly evolving healthcare ecosystem.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.